The short answer is yes, on one condition: research peptides can be bought and sold lawfully in the UK as laboratory reagents supplied for research, and only as that. What the law prohibits is supplying, advertising or presenting the same vial as something for people to take. The companion guide, what “research use only” means in the UK, explains the category; this page sets out the legislation that draws the line. It is general information, not legal advice.
What a “licensed medicine” is in UK law
The governing legislation is the Human Medicines Regulations 2012. Regulation 2 defines a “medicinal product” in two limbs: presentation — any substance “presented as having properties of preventing or treating disease in human beings” — and function, any substance that may be used by or administered to human beings to restore, correct or modify a physiological function by pharmacological, immunological or metabolic action, or to make a medical diagnosis. A product within the definition may, in general, be sold or supplied in the UK only under a marketing authorisation — a licence — granted through the Medicines and Healthcare products Regulatory Agency (MHRA).
Research peptides hold no such authorisation, and NorthScientific presents nothing it supplies as having any property in people. The sale prohibitions that follow are subject to narrow, prescriber-led exceptions in Part 10 — regulation 167’s “specials” route for individual patients, for example — none of which is open to a research supplier’s trade. With no authorisation in force and no exception applying, a supplier like NorthScientific has no lawful way to sell this material for human use.
Where the legal line sits
Regulation 46 contains the prohibition: a person “may not sell or supply, or offer to sell or supply, an unauthorised medicinal product” — one with no UK marketing authorisation or equivalent registration in force — and regulation 46(3) prohibits even possession with a view to sale or supply. Breach is an offence (regulation 47) carrying up to two years’ imprisonment on indictment. Advertising is restricted separately: an advertisement “includes anything designed to promote the prescription, supply, sale or use” of a medicinal product (regulation 7), and regulation 279 prohibits publishing one for an unauthorised product, in parallel limbs covering Great Britain and Northern Ireland — the whole of the UK — with breach an offence under regulation 303.
Where a research peptide sits against the definition is fact-specific. Supplied as a sealed reagent for laboratory work, described by its chemistry and carrying no claim about people, it is not presented as a medicine — and it is on that basis, NorthScientific’s position rather than any regulator’s ruling, that reagent supply proceeds; the MHRA has not classified these materials. Presenting the same vial as preventing or treating a condition, by contrast, brings it within the presentation limb of regulation 2; supplying it would then breach regulation 46, and promoting it regulation 279.
| Conduct | Position under the Regulations |
|---|---|
| Supplying a sealed lyophilised peptide as a laboratory reagent, described by name, format and fill weight | Not presented as a medicine; supplied on the basis that it sits outside regulation 2. Borderline classification is fact-specific. |
| Describing the same peptide as preventing, treating or helping with any condition in people | Presentation of the kind regulation 2 describes; supply would breach regulation 46, advertising regulation 279. |
| Publishing anything designed to promote use in people — a guide, a testimonial, a promotional reply | An advertisement within regulation 7; prohibited across the UK by regulation 279. |
The boundary in one sentence: research peptides are supplied lawfully in the UK as reagents for research, and only as that. “Research use only” on a vial is not a shield — a product presented or supplied for human use would be an unlicensed medicine whatever its label, and borderline classification rests with the MHRA, not the seller.
What this means for a buyer
For a laboratory, a research group or an individual purchasing for legitimate research, buying a research peptide as a reagent needs no licence, and nothing in the Human Medicines Regulations prohibits a purchase made on that research basis. The lawfulness is conditional: regulation 46(3) catches possession with a view to supply, and the research purpose keeps the transaction inside the category. NorthScientific’s terms of supply add a condition of sale: every purchaser confirms that they are at least 18, competent to handle laboratory reagents, and that the material will be used solely for research — not administered to any human or animal, and not resold or repackaged for that purpose. The mirror rule binds the supplier: NorthScientific does not sell for human use and gives no guidance on use in people — answering would take the supply outside its lawful category.
Recognising a supplier operating outside the line
Four things in a supplier’s own copy mark a storefront that has crossed the line:
- Guides to taking the product — preparation or administration instructions are promotion of use, not reagent supply.
- “Benefits” copy — outcomes in people, testimonials, before-and-after framing.
- Supplement-style framing — a reagent has no target demographic.
- Promotional replies in private — a direct message promoting use in people is advertising; regulation 7 excludes only non-promotional correspondence answering a specific question.
The wider due-diligence checklist is in how to choose a UK research peptide supplier.
The MHRA’s role in plain terms
In its own words, the MHRA “regulates medicines, medical devices and blood components for transfusion in the UK” — and that role reaches the boundary itself: through its borderline medicines team, it determines whether a product falls within the definition of a medicinal product — case by case, on claims, ingredients and presentation. It has made no determination on the materials NorthScientific supplies; nothing the company sells has been assessed, authorised or certified by the agency for any purpose.
Importing medicinal products into the UK requires the appropriate MHRA licence — an unlicensed medicine may be brought in only after prior notification to the agency — and an overseas seller’s presentation can itself bring a product within the definition: a peptide marketed abroad as something to take is likely to fall within the presentation limb. NorthScientific relies on no import route; it holds its range in UK stock.
The consumer-rights position
The research-use-only category does not remove consumer protection: an individual purchasing for legitimate research buys as a consumer, and under the Consumer Contracts (Information, Cancellation and Additional Charges) Regulations 2013 may cancel for any reason until 14 days after the day the goods come into their physical possession. Two statutory exceptions matter here: the right is lost for sealed goods unsuitable for return on health or hygiene grounds once unsealed, and it does not cover goods liable to deteriorate or expire rapidly — a vial with its crimp seal intact can be returned; an opened one cannot. The process is in section 8 of the terms. Under the Consumer Rights Act 2015 goods must also match their description — name, format and fill weight. Where they do not, the short-term right to reject runs for 30 days from the day after ownership has passed and the goods have been delivered, shorter for goods reasonably expected to perish sooner.
Common questions
Is BPC-157 legal in the UK?
The answer turns on presentation and purpose of supply, not the name of the compound; the MHRA has not classified it. Supplied as a sealed lyophilised reagent for laboratory research, BPC-157 is sold and bought on the basis that it sits outside the definition; presented or supplied for human use, the same vial would be an unlicensed medicine, and supplying it an offence under regulations 46 and 47. The same analysis applies to TB-500, GHK-Cu and the rest of the catalogue.
Is it legal to buy peptides in the UK?
Yes — as laboratory reagents for research. No licence is needed, and nothing in the Human Medicines Regulations prohibits a purchase made for research; the transaction stays lawful only on that narrow basis — a sealed reagent, sold for research, described by what it is.
NorthScientific’s position
NorthScientific is a trading name of KF01 LTD, registered in England and Wales, company number 17130830. It supplies eight research-use-only peptides as lyophilised powder in crimp-sealed vials, from UK stock, to research organisations, educational and commercial laboratories, and individuals purchasing for legitimate research, delivering within the United Kingdom only. It holds no marketing authorisation for any material and presents none as a medicine, food, cosmetic or supplement. It publishes what a material is — name, format, fill weight and, where established, sequence and identifiers — and does not publish independent third-party analysis. It gives no guidance on dosing, protocols, routes, schedules or quantities for any living subject, and its terms let it decline an order where eligibility checks fail. Questions about chemistry, format or terms: info@northscientific.co.uk. The position itself is simple: NorthScientific supplies laboratory reagents for research use only, and it does not supply anything for human or veterinary use.
Materials referenced: BPC-157 · TB-500 · GHK-Cu · full catalogue
Everything NorthScientific supplies is for laboratory research use only. Nothing on this page is dosing, preparation, administration or usage guidance, and nothing we sell is for human or veterinary consumption.